Nexthera files ind application for phase 1/2a clinical trial of nt-101 eye drop for wet amd

Busan, south korea--(business wire)-- #biopharmaceuticalcompany--nexthera submits an ind application for a clinical trial of nt-101 eye drop for wet amd, a leading cause of blindness in the elderly.

AMD Ratings Summary

AMD Quant Ranking